Parasite immunity and the major histocompatibility complex.
Parasite infestations offer fertile ground for investigation of the relationship between immunity, disease and the major histocompatibility complex (MHC). However, due to the complexities of parasite life cycles and the success of parasites in evading the immune response, immune reactions against the parasite often do not parallel protective immunity, and immunity does not imply lack of disease. -- An additional level of complexity is introduced in some forms of parasite immunity by accessory effector cells, e.g., macrophages and eosinophils, that need to be 'activated' for maximal effectiveness, and the 'activated' form of these cells may partly compensate for a deficiency in specific immune responses. -- It is not surprising, therefore, that polygenic effects operate in parasite immunity and reports linking non-MHC genes with parasite immunity far out number those linking MHC genes with it. From the reports that do link MHC genes with parasite immunity, two areas emerge that are interesting. First, the increased incidence of certain HLA genes in people with schistosomiasis who develop hepatosplenic disease may pinpoint individuals at risk of morbidity and direct early treatment to them. Second, mechanisms that intimately involve MHC products but are not linked to a particular MHC haplotype, may indicate newer areas in the investigation of parasite immunity.
D000818:Animals; D000917:Antibody Formation; D005873:Giardiasis / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate; D007896:Leishmaniasis / Q000276:immunology; D008285:Major Histocompatibility Complex; D008288:Malaria / Q000276:immunology; D010272:Parasitic Diseases / Q000276:immunology*; D012552:Schistosomiasis / Q000276:immunology; D014235:Trichinellosis / Q000276:immunology